Designing sub-20 nm self-assembled nanocarriers for small molecule delivery: Interplay among structural geometry, assembly energetics, and cargo release kinetics
Journal Article
·
· Journal of Controlled Release
- Univ. of California, Berkeley, CA (United States)
- Univ. of California, Berkeley, CA (United States); Univ. of Texas, Arlington, TX (United States)
- Univ. of California, Berkeley, CA (United States); Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Biological constraints in diseased tissues have motivated the need for small nanocarriers (10–30 nm) to achieve sufficient vascular extravasation and pervasive tumor penetration. Here, this particle size limit is only an order of magnitude larger than small molecules, such that cargo loading is better described by co-assembly processes rather than simple encapsulation. Understanding the structural, kinetic, and energetic contributions of carrier-cargo co-assembly is thus critical to achieve molecular-level control towards predictable in vivo behavior. These interconnected set of properties were systematically examined using sub-20 nm self-assembled nanocarriers known as three-helix micelles (3HM). Both hydrophobicity and the “geometric packing parameter” dictate small molecule compatibility with 3HM's alkyl tail core. Planar obelisk-like apomorphine and doxorubicin (DOX) molecules intercalated well within the 3HM core and near the core-shell interface, forming an integral component to the co-assembly, as corroborated by small-angle X-ray and neutron-scattering structural studies. DOX promoted crystalline alkyl tail ordering, which significantly increased (+63%) the activation energy of 3HM subunit exchange. Subsequently, 3HM-DOX displayed slow-release kinetics (t1/2 = 40 h) at physiological temperatures, with ~50× greater cargo preference for the micelle core as described by two drug partitioning coefficients (micellar core/shell Kp1 ~ 24, and shell/bulk solvent Kp2 ~ 2). The geometric and energetic insights between nanocarrier and their small molecule cargos developed here will aid in broader efforts to deconvolute the interconnected properties of carrier-drug co-assemblies. Adding this knowledge to pharmacological and immunological explorations will expand our understanding of nanomedicine behavior throughout all the physical and in vivo processes they are intended to encounter.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1840938
- Alternate ID(s):
- OSTI ID: 1785001
- Journal Information:
- Journal of Controlled Release, Journal Name: Journal of Controlled Release Vol. 329; ISSN 0168-3659
- Publisher:
- Controlled Release SocietyCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing
Chitosan-Gated Magnetic-Responsive Nanocarrier for Dual-Modal Optical Imaging, Switchable Drug Release, and Synergistic Therapy
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
Journal Article
·
Tue Sep 19 00:00:00 EDT 2023
· Nanoscale
·
OSTI ID:2470214
Chitosan-Gated Magnetic-Responsive Nanocarrier for Dual-Modal Optical Imaging, Switchable Drug Release, and Synergistic Therapy
Journal Article
·
Tue Jan 24 23:00:00 EST 2017
· Advanced Healthcare Materials
·
OSTI ID:1361983
Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
Journal Article
·
Wed Apr 13 00:00:00 EDT 2016
· Nature Communications
·
OSTI ID:1258344